We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Life Science Research Will Benefit from a New Hands-Free Mini Automated Cell Counter

By LabMedica International staff writers
Posted on 14 Apr 2011
A new instrument for the life science laboratory – a novel hands-free mini automated cell counter – has recently been released to the marketplace.

The Moxi Z mini cell counter is manufactured by ORFLO Technologies (Bothell, WA, USA) who describe it as the first portable instrument to provide cell viability without the use of reagents or dyes.

The Moxi Z combines two powerful methods, the Coulter Principle which is the gold standard for cell counting, and a patented thin-film sensor technology developed by ORFLO to allow particle sizing and counting over a broad size range (two to 34 microns). More...
In just eight seconds per measurement, the instrument provides accurate cell size and count determinations and an indicator of dead versus live cells based on the proprietary Moxi Viability Index. A measurement requires only 75 μl of sample volume in the 3,000 cells/mL to 500,000 cells/mL range, and the Moxi Z's disposable cassettes offer superior ease of use and cost effectiveness.

The instrument is small enough to fit in the palm of one hand, does not require a PC to operate, is easy to clean and does not require that a person hold it while performing a measurement, making it an ideal tool for the hood. Cleaning is simple with ethanol or Isopropyl alcohol.

While the Moxi Z is very robust with few moving parts and has been validated to be extremely stable over time, each unit is supplied with an Electronic Calibration Cassette to allow periodic checks of the accuracy of the instrument.

"The Moxi Z mini cell counter sets a new bar for the cell counting community,” said Manju Sethi, vice president of business development at ORFLO Technologies. "The instrument eliminates virtually all of the drawbacks of current cell counting methods.”

Related Links:
ORFLO Technologies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.